May 2021
Additional medications will require prior authorization for most members, starting May 24
What you need to know
For dates of service on or after May 24, 2021, you’ll need to submit prior authorization requests to AIM Specialty Health® for Cosela™ (trilaciclib) and Pepaxto® (melphalan flufenamide) for most members.
The following drugs covered under the medical benefit will require prior authorization for dates of service on or after May 24, 2021:
- Cosela™ (trilaciclib), HCPCS codes J3490, J3590, J9999, C9399
- Pepaxto® (melphalan flufenamide), HCPCS codes J3490, J3590, J9999, C9399
The prior authorization requirements apply when these drugs are administered in outpatient settings for:
- Members covered through Blue Cross Blue Shield of Michigan commercial fully insured groups except Michigan Education Special Services Association members
- Blue Cross commercial members with individual coverage
- Medicare Plus BlueSM members
- Blue Care Network commercial members
- BCN AdvantageSM members
These requirements don’t apply to Blue Cross commercial self-funded groups, including:
- Blue Cross and Blue Shield Federal Employee Program® members
- UAW Retiree Medical Benefits Trust non‑Medicare members
- All other Blue Cross commercial self-funded groups
How to submit authorization requests
Submit authorization requests to AIM using one of the following methods:
For information about registering for and accessing the AIM ProviderPortal, see the Frequently asked questions page** on the AIM website.
More about the authorization requirements
Authorization isn’t a guarantee of payment. Health care practitioners need to verify eligibility and benefits for members.
See the following documents for additional information on requirements related to drugs covered under the medical benefit:
- For commercial members:
- For Medicare Advantage members:
We’ll update the requirements lists with the new information prior to May 24, 2021.
**Blue Cross Blue Shield of Michigan and Blue Care Network don’t own or control this website. |